Using multiplex-bead-arrays, [71] identified new biomarkers (ApoA1, IL-1Ra, S100A12) for leprosy, confirmed five previously described biomarkers (CCL4, CRP, IL-10, IP-10, αPGL-1 IgM), and assessed their applicability in point-of-care (POC) tests. Here, CCL4 is linked to leprosy.